Intellia Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Good morning, everyone. My name is Gena Wang. I'm SMid-cap biotech analyst at Barclays. Welcome to our second Virtual Global Healthcare conference. First, I wish everyone is safe and healthy. And I would like to thank all the participants, investors, companies and especially our event team and corporate access team who made this virtual health care conference possible.
With that, I would like to introduce our next presenting company, Intellia. With us, we have John Leonard, Chief Executive Officer; Laura Sepp-Lorenzino, Chief Scientific Officer; and Glenn Goddard, Chief Financial Officer.
So with that, I will hand over to John for the introduction slides.
Thank you, Gena. So it's great to be here. Give us 1 second. We have a couple of slides that I think it will be helpful for the audience to get a sense while I just talk a little bit about Intellia. So maybe we can go to the next slide and show
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
